Information for Authors : Journal of the Egyptian Women’s Dermatologic Society

Secondary Logo

Journal Logo

Information for Authors

Aims and Scope:

The Journal of The Egyptian Women's Dermatologic Society (JEWDS) is an international peer reviewed journal. It is the official journal of the Egyptian Women's Dermatologic Society (EWDS). JEWDS aims to fill the knowledge gap in understanding the pathogenesis of dermatological diseases for better disease management by dermatologists around the world. Genetic, molecular, immunologic, microbiologic, biochemical and clinical trials original articles for skin diseases are the main scope of the journal. Review articles about the hot topics in dermatology are highly encouraged. The editorial board is interested in publishing studies about the following diseases; psoriasis, vitiligo, acne, hidradenitis supurativa, alopecia and mycosis fungoides. Submitted original articles, case reports, correspondence, review articles are published after double blinded peer reviewing.

JEWDS welcomes online submission from all the world. It is issued 3 times/year. JEWDS encourages Egyptian dermatological researchers to publish their valuable reviewed scientific work to be visible across the world through JEWDS website www​, OVID and SCOPUS.



JEWDS subscribes to the policies outlined in the ''Uniform Requirements for Manuscripts Submitted to Biomedical Journals'' written by the International Committee of Medical Journal Editors (www.ICMJE.or​g​​).


Redundant or Duplicate Publication. We ask the authors to confirm that the paper has not been published in its current form or a substantially similar form (in print or electronically, including on website), that it has not been accepted for publication elsewhere and that it is not under consideration for another publication. If you are in doubt (particularly in case of material that you have posted on a website), we ask you to proceed with your submission but to include a copy of the relevant previously published work or work under consideration by other journals. In the standard covering letter to the editors, draw attention to any published work that concern the same patients or subjects as the present patients or subjects as the present paper.

Important note. The journal is using software to screen for plagiarism for all submitted articles


Informed Consent. Authors reporting the results of studies involving human subjects, human-derived materials or human medical records must have obtained informed written consent.


Ethical approval of the study protocol from Research Ethics Committee of the institute is essential.


Requirement for Patient Consent Documents for Clinical Photographs. All clinical photographs submitted to JEWDS that permit identification of the patient in any way must be accompanied by a signed statement from the patient or guardian granting permission for publication of the photographs for educational purposes. In the case of a patient who is deceased, written permission must be provided by the patient's next of kin. It is not acceptable to place bars over the patient's features, but in cases where permissions are unobtainable, the photographs must be very tightly cropped to the feature being displayed. If identification is still possible after cropping, JEWDS cannot use the photograph. All submissions with clinical photographs must adhere to this policy and submit the proper documentation along with the manuscript or the submission cannot be accepted.


Copyright. Each author must sign a statement transferring copyright ownership to Egyptian Women's Dermatologic Society. Copyright transfer forms are available online at the journal's web site www​​.


Conflict of Interest. Authors should declare at the time of submission any conflict of interest with relating to competing company to product in the submitted manuscript. Reviewers and associate editors should disclose to the chief editor any relationships causing conflict of interest to manuscript under review.


Financial disclosure should be mentioned.


Permissions to Reproduce Previously Published Material

JEWDS requires you to send us copies of permission to reproduce material (such as illustrations) from the copyright holder of previously published material. Articles cannot be published without these permissions.



We ask all authors to confirm that they have read and approved the paper. Second, we ask all authors to confirm that they have met the criteria for authorship as established by the ICMJE, believe that the paper represents honest work, and are able to verify the validity of the results reported. All persons designated as authors should qualify for authorship and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the collection of data or general supervision of the research group, by themselves, do not justify authorship. All others who contributed to the work who are not authors should be named in the Acknowledgements section.


Corresponding Author. The editorial office must be supplied with phone and fax numbers and the e-mail address for the corresponding author. The editorial office must be notified of any changes in the order of authorship, author name change, address or phone number of the corresponding author. Always indicate the manuscript number in subsequent communications or correspondence.

Changes to authorship

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended.


Receipt of Manuscript Review Process and Revisions. Each manuscript will be acknowledged via e-mail in the order perceived. The acknowledgment will note the number assigned to the manuscript; this number should be referenced during all subsequent communications about the manuscript. This journal uses double-blind review, which means the identities of the authors are concealed from the reviewers, and vice versa. Therefore, the main body of the paper (including the references, figures, tables and any acknowledgements) should not include any identifying information, such as the authors' names or affiliations. Usually two and sometimes several reviewers will participate in the review of a manuscript. Re-review may be required after revision if, in the judgment of the editor, sufficient modification of the manuscript or data justifies another review cycle.



Original Articles: Original, in-depth clinical and investigative laboratory research papers. A structured abstract should be included. The text should not exceed 3500 words, excluding the abstract, references, figures, and tables—not to exceed 8 illustrations (figures and/or tables). For clinical trials, registration number of the study in a WHO-approved registry is required.


Reviews: A current review of a disease or treatment. The word count should not exceed 5000 words excluding the abstract, references, figures, and tables.


Case reports: They are formatted with introductory sentences, followed by report of a case and comment; they should not exceed 1000 words, 4 figures and 15 references.


Letter to the editor: Letters to the Editor may report original data, discuss published articles, or present hypotheses. Letters are not to exceed 1000 words, three figures or tables, and 15 references—not to exceed 3 printed journal pages. Research Letters should not be subdivided into sections, e.g. Introduction, Methods, Results, Discussion, etc. Letters that report original data will be reviewed.



Manuscripts should be prepared using Microsoft Word, 12 font-size, double spaced with 1-inch margins and left-justified text.

Title Page. The title page should include the following information:

1. Title–no longer than 135 characters. Declarative titles should not be used.

2. Names of authors–provide first name, middle initial, last name, and advanced degrees or professional certification.

3. Institutional affiliation–indicate each author's affiliation during the course of the study in footnotes on the title page using superscript numbers.

4. Meeting presentation–if the material has been presented previously, supply the name, place and date of the meeting.

5. Financial support–identify all sources, public and private. Provide the agency name and city, company name and city, fellowship

name and grant number.

6. Conflict of interest declaration

7. Running head–no longer than 40 characters.

8. Corresponding author–contact information for reprints.

Abstract. Each original article must include a structured abstract of no more than 300 words. The abstract must appear on a separate page and should include five separate sections: background, objective, patients and methods, results and conclusions. For review articles and case reports, the abstract is unstructured and not to exceed 200 words.

Keywords. Write 3-8 words in alphabetical order at the end of the abstract.

Text. All manuscripts must follow generally recognized standards for presenting scientific material. Introduction should refer only to the most pertinent past publications and should not be an extensive review of the literature. Methods should be written with sufficient detail to permit others to duplicate the work. Results must be concise and not simply a reiteration of data presented in tables. Discussion should be restricted to the significant findings presented. Digressions and speculation are not appropriate. References should follow text and begin on a separate page. They must be double spaced and numbered consecutively in order of appearance in the text. References should be designated by numbers before punctuation.

1. List only references that you have read and that are pertinent to the manuscript.

2. Cite only published studies as numbered references. You may acknowledge ''unpublished data'' or ''submitted'' articles within parentheses in the text. Reference to a ''personal communication'' within parentheses in the text must be accompanied by a signed permission letter from the individual being cited.

5. Books or articles ''in press'' may be cited as numbered references. Such citations should be updated before publication, if possible. Journal abbreviations should be those used by the National Library of Medicine, as found in Index Medicus. If in doubt as to the correct abbreviation, cite the complete journal name.

Please follow precisely the format and punctuation shown in the following examples.

Journal Article–(If 6 or fewer authors, list all) Waters JM, Richardson GD, Jahoda CA. Hair follicle stem cells. Semin Cell Dev Biol 2007; 18:245–254.

Journal Article–(If 7 or more authors, list only the first 6 and add et al.) Yu H, Fang D, Kumar SM, Li L, Nguyen TK, Acs G, et al. Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J Pathol 2006; 168:1879–1888.

Chapter in a Book–Daoud MS, Pittellkow MR. Lichen planus. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill Professional; 2003, pp. 464–477.

Book- Miller MC, Knapp RG. Clinical epidemiology and biostatistics. 3rd edition. Maryland: Williams & Wilkins, Harwal Pub Co; 1992.

Online Journal Article-LaPorte RE, Marler E, Akazawa S, Sauer F. The death of biomedical journals. JAMA [serial online]. 1996; 310:1387–90. Available at Accessed June 16, 1997.

Web Site–Health Care Financing Administration. 1996 statistics at a glance. Available at: Accessed December 2, 1997.

Tables. Do not embed tables within the body of the manuscript. Each table must be numbered consecutively using Arabic numbers, be mentioned in the text and be titled. Each column must have a heading. All abbreviations must be explained in the legend. Please do not place more than one table on a page.

Legends. Figure legends (photos, drawings, graphs) should be placed at the end of the manuscript. Do not embed figures within the body of the manuscript. Figures must be numbered consecutively as they appear in the text. For histologic figures, stains and magnifications should be noted in the legend. Any figure that has been published elsewhere should have an acknowledgment to the original source; a copy of the release to publish the figure, signed by the copyright holder, must also be submitted. Legends must

identify all symbols or letters that appear on the prints.

Abbreviations. Restrict abbreviations to those that are widely used and understood. Avoid abbreviations that have meaning only in the context of your specific manuscript. An abbreviation should appear first in parentheses immediately after the term or phrase to which it refers.

Drug/Manufacturer Names. Use generic names only in the text body. Include the trade name of a particular drug and the manufacturer's name and location, cited in parentheses, after the first use of the generic name. In the case of equipment, include manufacturer's name, city, state, and/or country.

Illustrations. Illustrations should be prepared according to the image guidelines for online manuscript submission.



JEWDS accepts online submission of manuscripts through Editorial Manager, which is linked to The site contains instructions and advice on how to use the system, guidance on the creation/scanning and saving of electronic art, and supporting documentation. Authors must use the format acceptable to Lippincott Williams & Wilkins, the publisher, in order to ensure proper publication in the print issues. Manuscripts not submitted in the correct format will be returned to authors for revision before peer review.

Black-and-white line drawings or grayscale figures should not be saved as color documents; this will increase file size without increasing the information content of the file.



Photomicrographs of histopathologic sections must be submitted in color. Authors are encouraged to submit other figures in color, when appropriate. Do not paste figures into word processing documents; submit them as separate files, without their captions. Label each file with its figure number and upload the figures in numerical order. The following summarizes our printer's guidelines for image preparation. Additional details can be found at

Please note: Images should be submitted in TIFF format. JPEG, GIFF, PowerPoint, Excel, MS Word, and downloaded Internet image files are not acceptable at this time.

Resolution: The minimum requirements for resolution are:

  • 1200 DPI/PPI for monochrome. For purely black and white images, such as line graphs and artistic renderings.
  • 300 DPI/PPI for halftones (CMYK/grayscale). For color or black-and-white images containing pictures only, including photographs not containing text labeling or thin lines.
  • 600 DPI/PPI for combination half tones (CMYK/grayscale).

For color or black-and-white images containing pictures and text labeling and/or thin lines. Lower resolutions may compromise print quality; higher resolutions will not improve output quality and will only increase file size.


Re-print charges. Authors requesting reprints for their accepted articles should pay charges of 1500 Egyptian pounds, 150 euros or 200 dollars. Reprint orders must be submitted prior to publication.